Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 138 member C (FAM138C, also known as F379 retina-specific protein) is a long noncoding RNA highly expressed in the human retina[2][5][1]. It was discovered as a retina-specific transcript with no significant homology to characterized protein-coding genes and encodes an unusual 85 amino acid putative protein, although current databases classify it as an lncRNA rather than a functional protein-coding gene[2][5][4]. FAM138C maps to subtelomeric regions of several chromosomes and is most abundant in retinal tissue, particularly in specialized cell types, but its precise biological function is not well established[1][2]. There is no evidence it is a classical druggable target (receptor, enzyme, channel, or transporter), nor are there established small molecule or biological modulators[5]. FAM138C has been linked loosely to a few conditions through transcriptomic studies, including visual epilepsy and autism spectrum disorder, but causality or mechanism is not established[5]. Expression is predominantly or exclusively retinal, and the gene may be useful as a retina-specific tissue marker, but there is no clinical biomarker or known therapeutic targeting[1][2][5]. The gene's transcripts incorporate repetitive elements (Alu, MIR), and its protein product, if present, is unique and lacks significant similarity to other known proteins[2][4]. While FAM138C is not a conventional therapeutic target, some confusion exists due to alternative names and early descriptions as a protein-coding gene; current authoritative sources classify it as a noncoding RNA[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 138 member C (FAM138C).